| # | Drug | Count |
|---|---|---|
| 0 | PEGINTERFERON ALFA-2A | 40 |
| 1 | RIBAVIRIN | 28 |
| 2 | RALTEGRAVIR | 12 |
| 3 | TENOFOVIR DISOPROXIL FUMARATE | 12 |
| 4 | RITONAVIR | 10 |
| 5 | MARIBAVIR | 8 |
| 6 | DARUNAVIR | 7 |
| 7 | DOLUTEGRAVIR SODIUM | 7 |
| 8 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 7 |
| 9 | LAMIVUDINE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | UNCARIA TOMENTOSA | 1 | 0.0082 |
| 1 | FOSAMPRENAVIR CALCIUM | 1 | 0.0076 |
| 2 | MARIBAVIR | 8 | 0.0032 |
| 3 | ADEFOVIR DIPIVOXIL | 3 | 0.0024 |
| 4 | RALTEGRAVIR | 12 | 0.0023 |
| 5 | MARAVIROC | 5 | 0.0022 |
| 6 | ELBASVIR AND GRAZOPREVIR | 5 | 0.0012 |
| 7 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 5 | 0.0008 |
| 8 | DOLUTEGRAVIR SODIUM | 7 | 0.0008 |
| 9 | LAMIVUDINE AND ZIDOVUDINE | 5 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 8 | 0.0032 |
| 1 | CCR5 Co-receptor Antagonist [EPC] | 5 | 0.0022 |
| 2 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 7 | 0.0004 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 17 | 0.0003 |
| 4 | Anthelmintic [EPC] | 1 | 0.0003 |
| 5 | Protease Inhibitor [EPC] | 15 | 0.0003 |
| 6 | Nucleoside Analog Antiviral [EPC] | 28 | 0.0003 |
| 7 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 8 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 33 | 0.0003 |
| 9 | Hepatitis C Virus NS5A Inhibitor [EPC] | 13 | 0.0003 |